Literature DB >> 21282980

Processive RNA decay by the exosome: merits of a quantitative Bayesian sampling approach.

Theresa Niederberger1, Sophia Hartung, Karl-Peter Hopfner, Achim Tresch.   

Abstract

RNA exosomes are large multi-subunit protein complexes involved in controlled and processive 3' to 5' RNA degradation. Exosomes form large molecular chambers and harbor multiple nuclease sites as well as RNA binding regions. This makes a quantitative kinetic analysis of RNA degradation with reliable parameter and error estimates challenging. For instance, recent quantitative biochemical assays revealed that degradation speed and efficiency depend on various factors, such as the type of RNA binding caps and the RNA length. We propose the combination of a differential equation model with bayesian Markov Chain Monte Carlo (MCMC) sampling for a more robust and reliable analysis of such complex kinetic systems. Using the exosome as a paradigm, it is shown that conventional "best fit" approaches to parameter estimation are outperformed by the MCMC method. The parameter distribution returned by MCMC sampling allows for a reliable and meaningful comparison of the data from different time series. In the case of the exosome, we find that the cap structures of the exosome have a direct effect on the recruitment and degradation of RNA, and that these effects are RNA length-dependent. The described approach can be widely applied to any processive reaction with a similar kinetics like the XRN1-dependent RNA degradation, RNA/DNA synthesis by polymerases, and protein synthesis by the ribosome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21282980      PMCID: PMC3127079          DOI: 10.4161/rna.8.1.14067

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  23 in total

1.  Structural framework for the mechanism of archaeal exosomes in RNA processing.

Authors:  Katharina Büttner; Katja Wenig; Karl-Peter Hopfner
Journal:  Mol Cell       Date:  2005-11-11       Impact factor: 17.970

2.  Structural basis of 3' end RNA recognition and exoribonucleolytic cleavage by an exosome RNase PH core.

Authors:  Esben Lorentzen; Elena Conti
Journal:  Mol Cell       Date:  2005-11-11       Impact factor: 17.970

3.  RNA degradation by the exosome is promoted by a nuclear polyadenylation complex.

Authors:  John LaCava; Jonathan Houseley; Cosmin Saveanu; Elisabeth Petfalski; Elizabeth Thompson; Alain Jacquier; David Tollervey
Journal:  Cell       Date:  2005-06-03       Impact factor: 41.582

Review 4.  RNA-quality control by the exosome.

Authors:  Jonathan Houseley; John LaCava; David Tollervey
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

5.  Structure of the nuclear exosome component Rrp6p reveals an interplay between the active site and the HRDC domain.

Authors:  Søren F Midtgaard; Jannie Assenholt; Anette Thyssen Jonstrup; Lan B Van; Torben Heick Jensen; Ditlev E Brodersen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

6.  The 3' to 5' degradation of yeast mRNAs is a general mechanism for mRNA turnover that requires the SKI2 DEVH box protein and 3' to 5' exonucleases of the exosome complex.

Authors:  J S Anderson; R P Parker
Journal:  EMBO J       Date:  1998-03-02       Impact factor: 11.598

7.  Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5'-->3' digestion of the transcript.

Authors:  D Muhlrad; C J Decker; R Parker
Journal:  Genes Dev       Date:  1994-04-01       Impact factor: 11.361

8.  RNA polyadenylation in Archaea: not observed in Haloferax while the exosome polynucleotidylates RNA in Sulfolobus.

Authors:  Victoria Portnoy; Elena Evguenieva-Hackenberg; Franziska Klein; Pamela Walter; Esben Lorentzen; Gabriele Klug; Gadi Schuster
Journal:  EMBO Rep       Date:  2005-12       Impact factor: 8.807

9.  The yeast exosome and human PM-Scl are related complexes of 3' --> 5' exonucleases.

Authors:  C Allmang; E Petfalski; A Podtelejnikov; M Mann; D Tollervey; P Mitchell
Journal:  Genes Dev       Date:  1999-08-15       Impact factor: 11.361

10.  Characterization of native and reconstituted exosome complexes from the hyperthermophilic archaeon Sulfolobus solfataricus.

Authors:  Pamela Walter; Franziska Klein; Esben Lorentzen; Anne Ilchmann; Gabriele Klug; Elena Evguenieva-Hackenberg
Journal:  Mol Microbiol       Date:  2006-11       Impact factor: 3.501

View more
  5 in total

Review 1.  Approaches for measuring the dynamics of RNA-protein interactions.

Authors:  Donny D Licatalosi; Xuan Ye; Eckhard Jankowsky
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-08-20       Impact factor: 9.957

Review 2.  Molecular characteristics and functional differences of anti-PM/Scl autoantibodies and two other distinct and unique supramolecular structures known as "EXOSOMES".

Authors:  Peter J Wermuth; Sergio A Jimenez
Journal:  Autoimmun Rev       Date:  2020-08-12       Impact factor: 9.754

3.  The Rrp4-exosome complex recruits and channels substrate RNA by a unique mechanism.

Authors:  Milos A Cvetkovic; Jan Philip Wurm; Maxime J Audin; Stefan Schütz; Remco Sprangers
Journal:  Nat Chem Biol       Date:  2017-03-13       Impact factor: 15.040

4.  EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia.

Authors:  Veronika Boczonadi; Juliane S Müller; Angela Pyle; Jennifer Munkley; Talya Dor; Jade Quartararo; Ileana Ferrero; Veronika Karcagi; Michele Giunta; Tuomo Polvikoski; Daniel Birchall; Agota Princzinger; Yuval Cinnamon; Susanne Lützkendorf; Henriett Piko; Mojgan Reza; Laura Florez; Mauro Santibanez-Koref; Helen Griffin; Markus Schuelke; Orly Elpeleg; Luba Kalaydjieva; Hanns Lochmüller; David J Elliott; Patrick F Chinnery; Shimon Edvardson; Rita Horvath
Journal:  Nat Commun       Date:  2014-07-03       Impact factor: 14.919

5.  Exosomal Protein Deficiencies: How Abnormal RNA Metabolism Results in Childhood-Onset Neurological Diseases.

Authors:  Juliane S Müller; Michele Giunta; Rita Horvath
Journal:  J Neuromuscul Dis       Date:  2015-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.